Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
10.73
-0.18 (-1.65%)
Sep 8, 2026, 3:52 PM EDT - Market open

Ardent Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
78.23135.81210.3453.9188.91154.26
Depreciation & Amortization
164.52155.7146.29140.84138.17137.2
Other Amortization
3.534.385.474.995.76.43
Loss (Gain) From Sale of Assets
-----161.16-0.11
Loss (Gain) on Equity Investments
-6.17-1.045.84-1.65-7.52-2.91
Stock-Based Compensation
35.6739.2917.980.90.610.55
Other Operating Activities
138.94139.71110.8779.02122.58112.61
Change in Accounts Receivable
63.5759.1640-181.1-17.18-96.47
Change in Inventory
2.54-3.15-9.411.674.67-5.73
Change in Accounts Payable
52.2562.06-103.86136.8214.42109.35
Change in Other Net Operating Assets
-18.75-121.41-108.49-13.7-327.56-268.28
Operating Cash Flow
514.32470.51315.03221.7-38.36146.91
Operating Cash Flow Growth
70.32%49.36%42.10%---7.94%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-209.57-211.9-187.51-137.41-151.11-139
Cash Acquisitions
-2.5-2.5-35.54---2.93
Divestitures
--4.3-206.370.65
Sale (Purchase) of Real Estate
-----3.56
Other Investing Activities
0.130.18-1.71-0.58-8.691.47
Investing Cash Flow
-211.94-214.23-220.46-137.9846.58-136.26

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---125204-
Long-Term Debt Issued
-15.6114.431.375.221,199
Total Debt Issued
21.6815.6114.4156.37209.221,199
Short-Term Debt Repaid
----125-202.05-
Long-Term Debt Repaid
--23.03-118.81-36.52-21.08-1,284
Total Debt Repaid
-28.73-23.03-118.81-161.52-223.13-1,284
Net Debt Issued (Repaid)
-7.05-7.42-104.42-5.15-13.91-84.61
Issuance of Common Stock
--208.66---
Repurchase of Common Stock
-13.03-----
Common Dividends Paid
-----174.81-62.13
Dividends Paid
-----174.81-62.13
Other Financing Activities
-98.45-96.04-79.6-97.11-81.61-137.17
Financing Cash Flow
-118.53-103.4724.64-102.26-270.33-283.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
183.85152.82119.21-18.55-262.11-273.26

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
304.76258.61127.5284.29-189.477.91
Free Cash Flow Growth
181.84%102.80%51.29%---
Free Cash Flow Margin
4.76%4.09%2.14%1.56%-3.69%0.16%
Free Cash Flow Per Share
2.151.830.960.67-1.50-
Levered Free Cash Flow
208.31154.2250.0755.07--
Unlevered Free Cash Flow
236.71184.3485.5996.52--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
65.7465.7474.9881.6190.85100.22
Cash Income Tax Paid
36.5136.5141.619.4355.8232.16
Change in Working Capital
99.61-3.34-181.75-56.31-325.65-261.13
SEC Filings: 10-K · 10-Q